Effect of Pneumovax II vaccination in high-risk individuals – (10-17-02)

Effect of Pneumovax II vaccination in high-risk individuals

The review article predicts only a 30% response to vaccine against the bacteria Pneumococci in high risk adults. You can assume that this response would drop even further in the general population. However, don’t start thinking that this would effect a nationwide push for mass vaccination. I would personally put my money on lifestyle changes designed to support and stimulate the immune system.

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: